Not Just Another Index.
It’s The New Generation.®
We offer specialized solutions for investors seeking exposure to New Listings - a proxy for economic growth and innovation.
New: The IPOX® High Dividend 7% Strategy
An Innovative Index Strategy
combining Income & Growth!
Upcoming Global IPOs
The IPOX® Newsletters
IPOX® in the News
On November 20, Central Bancompany shares climbed in their Nasdaq debut, securing a $5.26 billion valuation after raising $373 million. The listing continues a strong year for financial IPOs. IPOX® CEO Josef Schuster commented on investor confidence, stating, “The bank's successful trajectory fits well with investors looking for exposure to banks operating in markets with strong economic growth.” The Missouri-based lender manages $19.2 billion in assets.
Reuters highlighted Klook’s strong 2024 performance, revealing a 24% rise in revenue in its U.S. IPO filing. The SoftBank-backed platform seeks to list on the New York Stock Exchange as global travel rebounds. IPOX® Vice President Kat Liu noted Klook’s advantage in the underpenetrated travel experiences market while cautioning about thinner margins and fragmented supply. Goldman Sachs leads the offering’s underwriting team.
Dubai-based AIR, owner of the popular hookah brand Al Fakher, announced a $1.75 billion SPAC merger with Cantor Equity Partners III to list on Nasdaq as AIIR in 2026. The deal signals SPAC resurgence amid recovering markets, with the IPOX® SPAC Index outperforming equities on strong aftermarket performance. IPOX® Research Associate Lukas Muehlbauer highlighted lower interest rates easing capital access and diminishing risk perceptions for SPACs.
IPOX® Research Analyst Lukas Muehlbauer commented on Grupo Aeromexico's NYSE debut, where shares opened at $19.16, valuing the airline at $2.8 billion post-bankruptcy. The IPO raised $222.8 million amid regulatory scrutiny over Mexican routes and Delta joint venture. Muehlbauer noted investors are overlooking immediate concerns, buoyed by Aeromexico's recovery and efficient restructuring, though disputes may pressure stock performance until resolved.
In this First Trust Webinar, IPOX® Senior Investment Manager Kat Liu, CFA, delivers essential insights into the US IPO market and why IPO investment is important. She details the First Trust U.S. Equity Opportunities ETF (FPX), which employs systematic screening and a patented "1000 trading days" framework. FPX achieved 12.27% annualized returns since 2006 (as of 9/30/25), outperforming the S&P 500 with nearly 40% year-to-date gains.
The IPOX® Update
Global IPO activity intensifies with major U.S. filings including Blackstone-backed Copeland ($4.75B revenue), Grayscale ($35B AUM), and SoftBank-backed Klook ($417M revenue). Asia-Pacific markets see SBI Shinsei Bank's $2.1 billion Tokyo offering and Kbank's third KOSPI attempt. European developments feature BASF's 2027 Frankfurt listing plans and Bending Spoons eyeing a 2026 U.S. IPO at $11 billion valuation. IPOX analysts highlighted travel sector opportunities and cautioned about market volatility.
This week's IPO activity featured significant U.S. SPAC deals, including Dubai hookah maker AIR's $1.75 billion Nasdaq listing and Xanadu Quantum's $3.6 billion merger. Aeromexico successfully debuted on NYSE at a $2.8 billion valuation. International markets saw Malaysia's Sunway Healthcare planning a $1 billion IPO, while Germany's Mobile.de attracted interest ahead of a potential €10 billion listing. IPOX analysts highlighted SPAC revival momentum and MENA market valuation challenges.
OpenAI targets a record-breaking $1 trillion valuation, Medline files for a $50 billion listing, and Gloo Holdings readies a Nasdaq debut at $873 million. Meanwhile, the UK’s Doncasters eyes a 2026 New York offering, KR1 plans a London uplisting, and Pollon Life, backed by Jack Ma, files in Hong Kong, signaling renewed global confidence in major listings across regions.